http://www.onemedplace.com/blog The one place to find the companies, technologies and ideas shaping the future of healthcare Fri, 03 Jul 2009 21:19:21 +0000 http://backend.userland.com/rss092 en Scientists at the Scripps Research Institute have discovered the biological trigger for the autoimmune disease lupus. Researchers identified three proteins, called Toll-Like Receptors (TLRs), that can cause the immune system to turn against the body. The study was published June 29 in the Early Edition of the Proceedings of the ... http://www.onemedplace.com/blog/archives/2507 CombinatoRx has signed an all-stock merger agreement with Neuromed, a privately held Canadian biopharmaceutical company. Under the new agreement, CombinatoRx will issue approximately 36 million new shares of its stock to Neuromed stockholders. Each company will initially hold 50 percent of the merged organization. That number will be adjusted depending upon the ... http://www.onemedplace.com/blog/archives/2502 Cynosure, a manufacturer of lasers and light sources for medical and aesthetic use, has signed an agreement with Unilever to develop and commercialize light-based devices for home use. The multi-year agreement will focus on the skin rejuvenation segment of the marketplace, which aims to combat age-related wrinkles and lines. Unilever owns ... http://www.onemedplace.com/blog/archives/2491 Applied Spine Technologies, a device company dedicated to the treatment of chronic low back pain, has received permission from the U.S. Food and Drug Administration to restart a clinical trial of the Stabilimax NZ Dynamic Spine Stabilization System. The Stabilimax system is designed to stabilize the lumbar spine while still ... http://www.onemedplace.com/blog/archives/2485 CryoLife, which specializes in implantable biological devices and surgical adhesives, announced that, according to company data, CryoLife's BioGlue Surgical Adhesive has been used in more than 500,000 surgical procedures worldwide since its introduction in 1998.  Comprised of purified bovine serum albumin (BSA) and glutaraldehyde, BioGlue controls bleeding by creating a flexible seal ... http://www.onemedplace.com/blog/archives/2468 http://www.onemedplace.com/blog/archives/2459 Aureon Laboratories, a developer of predictive tests for cancer care, has been featured in a cable television segment produced by the Yonkers Chamber of Commerce. This Week In Yonkers: Business Spotlight highlights Aureon's efforts to develop a more accurate predictive test for prostate cancer. In the 15-minute segment, CEO Vijay Aggarwal discusses the principles behind Aureon's Prostate Px+ system. The test uses ... http://www.onemedplace.com/blog/archives/2449 Safeguard Scientifics, a Pennsylvania-based investor in information technology and life sciences companies, announced that its portfolio company Clarient has filed a registration statement with the Securities and Exchange Commission on Form S-3 relating to shares of Clarient owned by Safeguard. Safeguard President and CEO Peter J. Boni says that the ... http://www.onemedplace.com/blog/archives/2434 SyntheMed, a biomaterials company engaged in the development and commercialization of anti-adhesion products, has been nominated for the prestigious Frost & Sullivan Health Innovation Award in pediatrics. The Iselin, NJ-based company was recognized for its REPEL-CV Anti-Adhesion Barrier, a thin film designed to be placed over the heart at the ... http://www.onemedplace.com/blog/archives/2430 CNS Response announced that it has closed a $1 million bridge loan with venture capitalist John Pappajohn. Pappajohn has been involved in over 100 startups, including Caremark and Quantum Health. Over the past two months, CNS Response has closed two bridge loans totaling $1.2 million. The money will allow CNS Response, ... http://www.onemedplace.com/blog/archives/2418